Dear Colleagues,

Greetings from Fortis Cancer Institute

We cordially invite you to participate in the upcoming Fortis Cancer Summit - with the theme practice changing advances in precision oncology scheduled from 27^th Jan – 28^th Jan 2024 at Sheraton Grand Bengaluru Hotel at Brigade Gateway

Precision Oncology has made progress in leaps and bounds in recent years and is currently at the heart of revolutionizing cancer treatment. As this therapeutics continues to develop and evolve, the enhanced use of precision medicine in cancer treatment ultimately aims to improve prognosis and outcomes for patients.

Fortis Cancer Summit 2024 is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology.

The national faculty will include key oncologists (medical, surgical, radiation, hematological, interventional radiologists, and nuclear medicine physicians) across Fortis group of cancer institutes, as well as other senior oncologists of repute in the field of precision medicine.

The International faculty will include prominent names from the best institutes as well as prominent clinicians who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.

This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, debates, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties. The cancer summit will cover rapid updates. There will be collaborative sessions with radiologists, pathologists, intervention radiologists and nuclear medicine experts to discuss diagnostic tools and therapeutic oncology.

There will be a planned section for free papers, which will be used for posters and podium presentation. This will enable DM/MCh students or young doctors participate.

Prominent clinicians of Tier 2&3 cities of the region will also be there discussing the challenges and opportunities in these cities.

In addition to above, there will be multiple networking opportunities amongst oncology specialists and leaders of industry. Direct access to tomorrow's leaders as the summit will attract participation from many decision makers from tertiary care and super specialty hospitals

To summarize, at a larger level, the intent of fortis cancer summit is to create/ influence/ bring together key opinion leaders amongst the participant's across- faculty/ oncologists/ general physicians/ upcoming oncologists/ patients.

We look forward to seeing you soon in Bengaluru.